The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Other Relationship - UpToDate
Impact of pregnancy in women with desmoid fibromatosis: An international retrospective observational study.
 
Marco Fiore
No Relationships to Disclose
 
Sylvie Bonvalot
Honoraria - NANOBIOTIX
Travel, Accommodations, Expenses - PharmaMar
 
Giulia Personeni
No Relationships to Disclose
 
Chandrajit P Raut
No Relationships to Disclose
 
Kelly Mercier
Stock and Other Ownership Interests - Daiichi Sankyo Pharmaceutical; FibroGen; Jazz Pharmaceuticals; NeoGenomics Laboratories
 
Rebecca Gladdy
No Relationships to Disclose
 
Silva Ljevar
No Relationships to Disclose
 
Dimitrios Tzanis
No Relationships to Disclose
 
Enrica Rossi
No Relationships to Disclose
 
Megan Sulciner
No Relationships to Disclose
 
Harini Suraweera
No Relationships to Disclose
 
Chiara Colombo
No Relationships to Disclose
 
Mikhael Rabih
No Relationships to Disclose
 
Marianna Coppola
No Relationships to Disclose
 
Catherine Sarre-Lazcano
No Relationships to Disclose
 
Sara Iadecola
No Relationships to Disclose
 
Costanza Figura
No Relationships to Disclose
 
Daniela Salvatore
No Relationships to Disclose
 
Alessandro Gronchi
Honoraria - Deciphera; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar; SpringWorks Therapeutics
Research Funding - Nanobiotix (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar